Doug Melton, a molecular biologist whose life was changed by his child's diagnosis with Type 1 diabetes, is leading a promising new treatment that may replace insulin injections. By utilizing stem cells to create healthy insulin-producing cells, Melton and Vertex Pharmaceuticals are making significant strides in clinical trials. Recently recognized as Harvard's first Catalyst Professor, Melton's work exemplifies the potential of basic scientific discoveries in advancing medical treatments, a sentiment echoed by Hopi Hoekstra, Dean of the Faculty of Arts and Sciences at Harvard.
There are few things better than having an interesting science puzzle, especially one which involves educating people and that, if you're successful, does some good for people in the world.
At a time when investment in science is under attack, it is hard to imagine a better example of how basic scientific discovery paves the way for breakthroughs in medicine.
Collection
[
|
...
]